SE452107B - ANTIPERPIRANT COMPOSITION CONTAINING AN ALUMINUM CHLORIDE AND AN ALUMINUM ZIRCONIUM HYDROXICLORIDE AS ACTIVE INGREDIENTS - Google Patents
ANTIPERPIRANT COMPOSITION CONTAINING AN ALUMINUM CHLORIDE AND AN ALUMINUM ZIRCONIUM HYDROXICLORIDE AS ACTIVE INGREDIENTSInfo
- Publication number
- SE452107B SE452107B SE8103369A SE8103369A SE452107B SE 452107 B SE452107 B SE 452107B SE 8103369 A SE8103369 A SE 8103369A SE 8103369 A SE8103369 A SE 8103369A SE 452107 B SE452107 B SE 452107B
- Authority
- SE
- Sweden
- Prior art keywords
- composition
- aluminum
- weight
- composition according
- aluminum chloride
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Description
40 452 107 Uppfinningen avser därför en antiperspirantkomposition inne- fattande en bärare och ett aktivt antiperspirantmaterial, var- vid kompositionen utmärkes av, att den som aktivt antiperspi- rantmaterial innefattar en kombination av en aluminiumklorid och en aluminiumzirkoniumhydroxiklorid, varvid aluminiumklo- riden ingår i en mängd av 5-25 vikt%, räknat på kompositionens å totala vikt, och aluminiumzirkoniumhydroxikloriden ingår i en mängd av 2-20 %, räknat på kompositionens totala vikt, och var- vid förhållandet aluminiumsalt till Al/Zr-salt i kompositionen är 0,5-2 och molförhållandet metall till klorid är mindre än 0,9, och att den eventuellt innefattar ett pH-reglerande medel. The invention therefore relates to an antiperspirant composition comprising a carrier and an active antiperspirant material, wherein the composition is characterized in that it comprises as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxychloride, the aluminum chloride being present in an amount of 5-25% by weight, based on the total weight of the composition, and the aluminum zirconium hydroxychloride is present in an amount of 2-20%, calculated on the total weight of the composition, and wherein the ratio of aluminum salt to Al / Zr salt in the composition is 0.5 -2 and the molar ratio of metal to chloride is less than 0.9, and that it optionally comprises a pH adjusting agent.
N) -_-f.-.--.-"^“\f".""tfætllißbiïf Uppfinningen beskrivs närmare nedan i detalj, varvid de angivna procentangivelserna avser viktprocent räknat på kompositionens totala vikt, om ej annat anges.N) -_- f.-. - .- "^“ \ f "." "Tfætllißbiïf The invention is described in more detail below, the stated percentages being by weight percent on the total weight of the composition, unless otherwise indicated.
Det är känt att vissa människor svarar på speciella typer av antiperspirantsalter; det är ovanligt att mer än 60-70 % av en antiperspirantpanel svarar på ett givet material. När emeller- tid kombinationen av aktiva beståndsdelar enligt föreliggande uppfinning användes uppvisade över 93 % av deltagarna i pane- len ett gynnsamt svar. Dessutom registrerades överraskande höga aktiviteter; 88 % uppvisade överlägsen aktivitet. Det har all- tid antagits att aktivitetsmekanismen varierar mellan olika salter. Det vi har upptäckt är en kombinationsprodukt, som möjliggör aktivitetssvar från mer än en mekanism.It is known that some people respond to special types of antiperspirant salts; it is unusual for more than 60-70% of an antiperspirant panel to respond to a given material. However, when the combination of active ingredients of the present invention is used, over 93% of the panelists showed a favorable response. In addition, surprisingly high levels of activity were recorded; 88% showed superior activity. It has always been assumed that the activity mechanism varies between different salts. What we have discovered is a combination product, which enables activity responses from more than one mechanism.
Normalt sett skulle man ha förväntat sig att kombinationen en- ligt uppfinningen skulle ge en kraftig irritation av huden, eftersom kombinationens pH-värde är mycket surt. Det har även visat sig att enbart en ökning av pH-värdet icke är tillräck- lig för att mildra irritationssvaret. Vi har emellertid upp- täckt att användningen av tvåvärda oxider eller hydroxider i kombination med små mängder glycin löser detta problem. Jord- alkalimetallsalter eller glycin använda var för sig kan för- bättra det potentiella irritationsproblemet något; problemet kan emellertid i stort sett elimineras fullständigt genom an- vändning av en kombination av tvåvärda metalloxider eller -hydroxider och glycin.Normally, one would have expected the combination according to the invention to cause a severe irritation of the skin, since the pH value of the combination is very acidic. It has also been shown that an increase in the pH value alone is not sufficient to alleviate the irritation response. However, we have discovered that the use of divalent oxides or hydroxides in combination with small amounts of glycine solves this problem. Alkaline earth metal salts or glycine used alone can slightly improve the potential irritation problem; however, the problem can be largely completely eliminated by the use of a combination of divalent metal oxides or hydroxides and glycine.
Den mängd aluminiumklorid som kan ingå i kompositionerna en- 452 107 ligt föreliggande uppfinning kan variera något. Mestadels utgör mängden aluminiumklorid 5-25 vikt%, räknat på komposi- tionens totala vikt, och företrädesvis 7,5-15 vikt%. Med uttrycket "aluminiumklorid" avses i föreliggande samanhang såväl vattenfri aluminiumklorid som hydratiserade former och hydroxidformer därav, exempelvis AlCl3 - 6H20 eller A12 (OH) 501 .The amount of aluminum chloride that may be included in the compositions of the present invention may vary slightly. Mostly, the amount of aluminum chloride is 5-25% by weight, based on the total weight of the composition, and preferably 7.5-15% by weight. The term "aluminum chloride" as used herein means both anhydrous aluminum chloride and hydrated forms and hydroxide forms thereof, for example AlCl 3 - 6H 2 O or Al 2 (OH) 501.
De aluminiumzirkoniumhydroxiklorider som används enligt före- liggande uppfinning är väl kända inom tekniken och kan åskåd- ä m! liggöras med den allmänna formeln A14 ZnO(OH)l4_n Cln X H20 vari n har värdet 0-14 och x har värdet 0-20. Som exempel kan nämnas föreningar med formlerna Al4 ZrO (OH)ll C13 och Al ZIO (OH)l0 C14 och motsvarande hydrater.The aluminum zirconium hydroxychlorides used in the present invention are well known in the art and can be seen. is prepared by the general formula A14 ZnO (OH) 14_n Cln X H 2 O where n has the value 0-14 and x has the value 0-20. Examples which may be mentioned are compounds of the formulas A14 ZrO (OH) II C13 and Al Z10 (OH) 10 C14 and corresponding hydrates.
Den mängd aluminiumzirkoniumhydroxiklorid som kan ingå i kompositionerna enligt uppfinningen kan även variera något.The amount of aluminum zirconium hydroxychloride that may be included in the compositions of the invention may also vary somewhat.
Vanligen är emellertid mängden därav 2-20 vikt%, räknat på kompositionens totala vikt, och företrädesvis 5-10 vikt%.Usually, however, the amount thereof is 2-20% by weight, based on the total weight of the composition, and preferably 5-10% by weight.
Ett väsentligt särdrag hos kompositionerna enligt uppfinning- en är förhållandet mellan aluminiumsaltet och Al/Zr-saltet.An essential feature of the compositions of the invention is the ratio of the aluminum salt to the Al / Zr salt.
Detta förhållande är 0,5-2, varvid det föredragna intervallet är 1,25-1,75.This ratio is 0.5-2, with the preferred range being 1.25-1.75.
Ett annat väsentligt särdrag hos kompositionerna enligt upp- Tinningen är molförhâllandet metallzklorid. Det är viktigt att detta är mindre än 0,9 för att komplexets jonkaraktär skall bibehållas, vilket är relaterat till dess antiperspi- rantaktivitet. 452 102 Såsom antytts ovan är det synnerligen fördelaktigt att använ- da en kombination av magnesiumhydroxid (eller magnesiumoxid) och glycin för att reglera kompositionernas pH-värde. Denna kombination används vanligen för att inställa pH inom inter- vallet 2,5-4,5. Glycin används i en halt av 0,25-5 vikt%, räknat på kompositionens totala vikt, medan magnesiumhydroxi- - den (eller magnesiumoxiden) utgör 1-9 vikt%. Förhållandet glycin till magnesiumhydroxid (eller magnesiumoxid) är även en väsentlig faktor. Detta förhållande kan ligga inom inter- vallet 0,025-5 men ligger företrädesvis inom intervallet 0,1- 1,0.Another essential feature of the compositions according to the invention is the molar ratio of metal chloride. It is important that this is less than 0.9 in order to maintain the ionic character of the complex, which is related to its antiperspirant activity. 452 102 As indicated above, it is particularly advantageous to use a combination of magnesium hydroxide (or magnesium oxide) and glycine to control the pH of the compositions. This combination is usually used to adjust the pH in the range 2.5-4.5. Glycine is used in a content of 0.25-5% by weight, based on the total weight of the composition, while the magnesium hydroxide (or magnesium oxide) constitutes 1-9% by weight. The ratio of glycine to magnesium hydroxide (or magnesium oxide) is also an important factor. This ratio may be in the range 0.025-5 but is preferably in the range 0.1-1.0.
Den nya kombinationen av antiperspirantmaterial och pH-reg- lerande medel kan införlivas med varje doseringsform som är användbar för utportionering av antiperspirantmaterialet. De aktiva beståndsdelarna kan således införlivas med en lotion, en kräm eller gel, ett skumsystem, ett aerosolsystem, ett pumpspraysystem eller som en del av ett antiperspirantstift eller också kan det införlivas i form av en lösning med en lämplig lösningsmedelsbärare. Nedan återges exempel på bered- ningar, i vilka kompositionerna enligt uppfinningen kan an- vändas som aktiva antiperspirantmedel: A. Roll-On (lotioner och krämer) Aktiva beståndsdelar 25% Lenande medel 2-4% Ytaktiva medel 2-4% Buffertsystem 2-7% Vatten till lOO% B. vattenfri suspension som kan användas i aerosol- och aerosolskumberedningar Aktiva beståndsdelar 25% Lenande medel 5-15% Suspenderingsmedel 2-5% Buffertmedel 2-4% Vatten till 100% 452 107 Aerosol Komposition enligt ovan 70-85% Drivmedel 15-30% C. §§¿§E Aktiva beståndsdelar 25% Gelningsmedel 2-4% Vaxer 5-20% Lenande medel 5-20% Buffertmedel 2-4% Yttre fas (vattenfritt lösningsmedel) till' 100% Uppfinningen âskådliggörs närmare medelst följande utförings- exempel.The new combination of antiperspirant material and pH adjusting agent can be incorporated into any dosage form useful for dispensing the antiperspirant material. Thus, the active ingredients may be incorporated into a lotion, a cream or gel, a foam system, an aerosol system, a pump spray system or as part of an antiperspirant pen, or it may be incorporated in the form of a solution with a suitable solvent carrier. Below are examples of preparations in which the compositions according to the invention can be used as active antiperspirants: A. Roll-On (lotions and creams) Active ingredients 25% Soothing agent 2-4% Surfactants 2-4% Buffer system 2- 7% Water to 100% B. Anhydrous suspension that can be used in aerosol and aerosol foam preparations Active ingredients 25% Soothing agent 5-15% Suspending agent 2-5% Buffer agent 2-4% Water to 100% 452 107 Aerosol Composition as above 70- 85% Fuel 15-30% C. §§¿§E Active ingredients 25% Gelling agent 2-4% Waxes 5-20% Soothing agent 5-20% Buffer agent 2-4% Outer phase (anhydrous solvent) to 100% The invention is illustrated in more detail by means of the following embodiments.
Exemgel l Roll-On-lotion (emulsion av olja i vatten) .Yålfi AlCl3 - 6H2O 15,00 Mg(OH)2 3,75 Al/Zr-triklorhydratl 10,00 Brij 72 (polyoxietylen 2 stearyleter) 3,00 Brij 78 (polyoxietylen 20 stearyleter) 1,00 Glycin 0.50 Dinatrium-EDTA 0,10 Polyoxipropylen 15 stearyleter (Arlamol E) 4,00 H20 62,65 100,00 452 107 6 Exemgel 2 Klar vattenlösning (pumpspray) Vikt% A1C13 - 6H2o 15,00 Mg(OH)2 3,75 Glycin 0,50 Al/Zr-triklorhydratl 10,00 H20 65,75 Procetyl AWS (PPG-5 Cetheth 20) 5,00 100,00 Exemgel 3 Aerosol-antiperspirant Vikt% Al-komplex-pulverz 6,00 Al/zr-triklorhydratl 4 , oo Dibutylftalat ll,O0 Carbosil M-5 0,30 Bentone 34 0,10 Isobutan 78,60 100,00 Exemgel 4 Antigersgirantstift Vikt% Al-komplex-pulver 15,00 Al/Zr-triklorhydrat 10,00 Stearylalkøhol 20,00 Dibutylftalat 41,00 Procetyl AWS (PPG-5 Cethath 20) 10,00 Montanvax 4,00 100,00 l êl4ZrO(OH)llCl3 Produkt framställd genøm spraytorkning av AlCl3; Mg(OH)2 och glycin i viktförhållandet 4:l:0,5. ' 452 107 I syfte att demonstrera det faktum att kombinationen av aluminiumklorid och aluminiumzirkoniumhydroxiklorid ger en synergistisk effekt som antiperspiranter, framställdes tre kompositioner A, B och C, vilka uppvisade samma sammansätt- ning med undantag av det aktiva antiperspirantmedlet. Kompo- sition A innehöll 25 vikt% aluminiumzirkoniumhydroxiklorid, komposition B innehöll 10 vikt% aluminiumzirkoniumhydroxi- klorid och 15 vikt% aluminiumklorid och komposition C inne- höll 25 vikt% aluminiumklorid. Var och en av dessa komposi- tioner testades med avseende pâ antiperspirantaktivitet på en grupp personer, som ingick i en antiperspirantpanel. Det använda förfarandet finns beskrivet i Federal Register, Vol. 43, No. 196, 10 oktober 1978 och benämns gravemetriskt arm- håleantiperspiranttest.Example gel 1 Roll-On lotion (emulsion of oil in water). Yal AlCl 3 - 6H 2 O 15.00 Mg (OH) 2 3.75 Al / Zr trichlorohydrate 10.00 Brij 72 (polyoxyethylene 2 stearyl ether) 3.00 Brij 78 (polyoxyethylene 20 stearyl ether) 1.00 Glycine 0.50 Disodium EDTA 0.10 Polyoxypropylene 15 stearyl ether (Arlamol E) 4.00 H 2 O 62.65 100.00 452 107 6 Example gel 2 Clear aqueous solution (pump spray) Weight% AlCl 3 - 6H 2 O 15, 00 Mg (OH) 2 3.75 Glycine 0.50 Al / Zr trichlorohydratel 10.00 H 2 O 65.75 Procetyl AWS (PPG-5 Cetheth 20) 5.00 100.00 Example gel 3 Aerosol antiperspirant Weight% Al complex powder 6.00 Al / zr-trichlorohydratel 4, oo Dibutyl phthalate ll, O0 Carbosil M-5 0.30 Bentone 34 0.10 Isobutane 78.60 100.00 Exemgel 4 Antigersgirantstift Weight% Al complex powder 15.00 Al / Zr-trichlorohydrate 10.00 Stearyl alcohol 20.00 Dibutyl phthalate 41.00 Procetyl AWS (PPG-5 Cethath 20) 10.00 Montan wax 4.00 100.00 l êl4ZrO (OH) llCl3 Product prepared by spray drying of AlCl3; Mg (OH) 2 and glycine in the weight ratio 4: 1: 0.5. '452 107 In order to demonstrate the fact that the combination of aluminum chloride and aluminum zirconium hydroxychloride gives a synergistic effect as antiperspirants, three compositions A, B and C were prepared which showed the same composition with the exception of the active antiperspirant. Composition A contained 25% by weight of aluminum zirconium hydroxychloride, Composition B contained 10% by weight of aluminum zirconium hydroxychloride and 15% by weight of aluminum chloride and Composition C contained 25% by weight of aluminum chloride. Each of these compositions was tested for antiperspirant activity in a group of individuals who were part of an antiperspirant panel. The procedure used is described in the Federal Register, Vol. 43, no. 196, October 10, 1978 and is called a gravemetric armpit antiperspirant test.
Resultaten av detta test återges i tabell I nedan, som åter- ger sammansättningarna för kompositionerna A, B och C lik- som den för varje komposition uppmätta antiperspirantakti- viteten.The results of this test are set forth in Table I below, which shows the compositions of compositions A, B and C as well as the antiperspirant activity measured for each composition.
Tabell I .ê ä 9.Table I .ê ä 9.
Aluminiumzirkonium- hydroxidkomplex 25 10 -- Aiuminiumkloria ' -- 15 25 Lenande medel 2-4 2-4 2-4 Ytaktiva medel 2-4 2-4 2-4 q.s. buffert till pH 3,2 ïo,3 q.s. vatten till 100% pH vid tidpunkten för testet 3,5 3,2 3,4 Aktivitet 50% 62% 53% Som framgår av tabellen ovan uppnås en 20-25%-ig förbättring av antiperspirantaktiviteten med en kombination av aluminium- klorid och aluminiumzirkoniumhydroxiklorid, jämfört med an- vändningen av aluminiumklorid eller aluminiumzirkoniumhydroxi- klorid var för sig.Aluminum-zirconium hydroxide complex 25 10 - Aluminum chloride '- 15 25 Soothing agents 2-4 2-4 2-4 Surfactants 2-4 2-4 2-4 q.s. buffer to pH 3.2 β, 3 q.s. water to 100% pH at the time of the test 3.5 3.2 3.4 Activity 50% 62% 53% As shown in the table above, a 20-25% improvement in antiperspirant activity is achieved with a combination of aluminum chloride and aluminum zirconium hydroxychloride , compared with the use of aluminum chloride or aluminum zirconium hydroxychloride separately.
Claims (9)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15311380A | 1980-05-27 | 1980-05-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8103369L SE8103369L (en) | 1981-11-28 |
| SE452107B true SE452107B (en) | 1987-11-16 |
Family
ID=22545825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8103369A SE452107B (en) | 1980-05-27 | 1981-05-27 | ANTIPERPIRANT COMPOSITION CONTAINING AN ALUMINUM CHLORIDE AND AN ALUMINUM ZIRCONIUM HYDROXICLORIDE AS ACTIVE INGREDIENTS |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5711908A (en) |
| AU (1) | AU547530B2 (en) |
| BE (1) | BE888975A (en) |
| CA (1) | CA1140470A (en) |
| CH (1) | CH644755A5 (en) |
| DE (1) | DE3120742A1 (en) |
| FR (1) | FR2483230A1 (en) |
| GB (1) | GB2076289B (en) |
| GR (1) | GR75643B (en) |
| IT (1) | IT1170993B (en) |
| MX (1) | MX156358A (en) |
| NL (1) | NL8102540A (en) |
| NZ (1) | NZ197164A (en) |
| PH (1) | PH16329A (en) |
| PT (1) | PT73090B (en) |
| SE (1) | SE452107B (en) |
| ZA (1) | ZA813484B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4774079A (en) * | 1980-12-15 | 1988-09-27 | Bristol-Myers Company | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
| CA1153313A (en) * | 1980-12-15 | 1983-09-06 | Chung T. Shin | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
| US4606915A (en) * | 1981-04-23 | 1986-08-19 | Bristol-Myers Company | Antiperspirant combination containing an aluminum halohydrate and a stannic halide |
| US5114705A (en) * | 1983-08-16 | 1992-05-19 | The Gillette Company | Antiperspirant composition |
| US4775528A (en) * | 1983-08-16 | 1988-10-04 | The Gillette Company | Antiperspirant composition |
| GB2144992A (en) * | 1983-08-16 | 1985-03-20 | Gillette Co | Antiperspirants |
| US5589196A (en) * | 1983-08-16 | 1996-12-31 | The Gillette Company | Antiperspirant composition |
| US4673570A (en) * | 1985-03-20 | 1987-06-16 | Carter-Wallace, Inc. | Gelled antiperspirant compositions |
| JPH05112440A (en) * | 1991-08-09 | 1993-05-07 | Sayuri Takemoto | Coating agent for deodorization |
| US6136302A (en) * | 1999-02-18 | 2000-10-24 | The Procter & Gamble Company | Process of making zirconium-aluminum antiperspirant active |
| US6375937B1 (en) | 2000-10-20 | 2002-04-23 | Colgate-Palmolive Company | Antiperspirant salts for enhanced cosmetic products |
| FR2828646B1 (en) | 2001-08-17 | 2004-11-26 | Oreal | ANHYDROUS ANTITRANSPIRANT STICK |
| US20040109833A1 (en) | 2002-12-09 | 2004-06-10 | Xiaozhong Tang | High efficacy, low irritation aluminum salts and related products |
| US7905673B2 (en) | 2003-11-17 | 2011-03-15 | The Procter & Gamble Company | Antiperspirant composition and applicator therefor |
| US8815222B2 (en) * | 2009-12-23 | 2014-08-26 | Colgate—Palmolive Company | Anhydrous liquid antiperspirant composition |
| RU2672245C1 (en) | 2013-11-18 | 2018-11-13 | Колгейт-Палмолив Компани, Сша | Antiperspirant composition |
| US10342749B2 (en) | 2014-12-15 | 2019-07-09 | Conopco, Inc. | Antiperspirant compositions comprising alums |
| US9572758B2 (en) | 2015-06-30 | 2017-02-21 | Gulbrandsen Technologies, Inc. | Method of making high performance activated aluminum sesquichlorohydrate powders |
| US20170128332A1 (en) * | 2015-11-09 | 2017-05-11 | Gulbrandsen Technologies, Inc. | Activation and stabilization of basic aluminum chloride solution by zinc |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906668A (en) * | 1955-06-13 | 1959-09-29 | Reheis Company Inc | Zirconyl and aluminum halohydroxy complex |
| US3903258A (en) * | 1973-08-06 | 1975-09-02 | Gillette Co | Zirconium aluminum complexes and method of making the same |
| US3981986A (en) * | 1973-11-23 | 1976-09-21 | Armour Pharmaceutical Company | Zirconium-aluminum-polyol buffered anti-perspirant complexes |
| US4017599A (en) * | 1973-11-23 | 1977-04-12 | Armour Pharmaceutical Company | Aluminum-zirconium anti-perspirant systems with salts of amino acids |
| AU8303275A (en) * | 1974-07-17 | 1977-01-20 | Armour Pharma | Aluminum-zirconium antiperspirant systems with trace amounts of alkaline earth metals |
| JPS5454863A (en) * | 1977-10-03 | 1979-05-01 | Kubota Ltd | Stalk and straw conveying apparatus with safety cover |
-
1980
- 1980-07-09 CA CA000355786A patent/CA1140470A/en not_active Expired
-
1981
- 1981-05-21 NZ NZ197164A patent/NZ197164A/en unknown
- 1981-05-21 AU AU70928/81A patent/AU547530B2/en not_active Ceased
- 1981-05-22 FR FR8110236A patent/FR2483230A1/en active Granted
- 1981-05-22 NL NL8102540A patent/NL8102540A/en not_active Application Discontinuation
- 1981-05-22 GR GR65041A patent/GR75643B/el unknown
- 1981-05-25 ZA ZA00813484A patent/ZA813484B/en unknown
- 1981-05-25 DE DE19813120742 patent/DE3120742A1/en active Granted
- 1981-05-25 IT IT48527/81A patent/IT1170993B/en active
- 1981-05-26 PT PT73090A patent/PT73090B/en unknown
- 1981-05-26 CH CH345681A patent/CH644755A5/en not_active IP Right Cessation
- 1981-05-26 BE BE0/204911A patent/BE888975A/en not_active IP Right Cessation
- 1981-05-26 MX MX187478A patent/MX156358A/en unknown
- 1981-05-26 GB GB8116054A patent/GB2076289B/en not_active Expired
- 1981-05-27 JP JP7944281A patent/JPS5711908A/en active Granted
- 1981-05-27 PH PH25676A patent/PH16329A/en unknown
- 1981-05-27 SE SE8103369A patent/SE452107B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1140470A (en) | 1983-02-01 |
| PH16329A (en) | 1983-09-05 |
| GB2076289B (en) | 1985-01-09 |
| JPS6412245B2 (en) | 1989-02-28 |
| AU7092881A (en) | 1981-12-03 |
| IT1170993B (en) | 1987-06-03 |
| FR2483230B1 (en) | 1985-01-04 |
| BE888975A (en) | 1981-11-26 |
| AU547530B2 (en) | 1985-10-24 |
| IT8148527A0 (en) | 1981-05-25 |
| JPS5711908A (en) | 1982-01-21 |
| GR75643B (en) | 1984-08-02 |
| DE3120742A1 (en) | 1982-03-18 |
| CH644755A5 (en) | 1984-08-31 |
| PT73090B (en) | 1983-02-08 |
| PT73090A (en) | 1981-06-01 |
| NL8102540A (en) | 1981-12-16 |
| MX156358A (en) | 1988-08-12 |
| DE3120742C2 (en) | 1988-10-27 |
| NZ197164A (en) | 1984-08-24 |
| GB2076289A (en) | 1981-12-02 |
| SE8103369L (en) | 1981-11-28 |
| FR2483230A1 (en) | 1981-12-04 |
| ZA813484B (en) | 1982-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE452107B (en) | ANTIPERPIRANT COMPOSITION CONTAINING AN ALUMINUM CHLORIDE AND AN ALUMINUM ZIRCONIUM HYDROXICLORIDE AS ACTIVE INGREDIENTS | |
| US6495149B1 (en) | Topical leave-on compositions containing selected pantothenic acid derivatives | |
| CA1172572A (en) | Antiperspirant composition | |
| US8747821B2 (en) | Transparent cosmetic or dermatological formulation | |
| US4073880A (en) | Antiperspirant solution containing a substantially volatile polydimethyl siloxane liquid | |
| US20150118173A1 (en) | Formulation comprising caprylic acid ethanolamide and/or capric acid ethanolamide in combination with an aluminium salt and its use | |
| JP2002523347A (en) | Antiperspirant composition containing calcium salt | |
| BRPI0616015A2 (en) | anhydrous based composition, anhydrous aerosol composition and process for manufacturing an anhydrous antiperspirant aerosol composition | |
| EP1755544B1 (en) | Antiperspirant or deodorant compositions | |
| JP2004500306A (en) | Underarm cosmetic composition containing lower alkyl acetate | |
| US4021536A (en) | Magnesium-zirconium complexes useful as antiperspirants | |
| US20060067901A1 (en) | Antiperspirant compositions | |
| WO2019206764A1 (en) | An antiperspirant composition | |
| AU2022287610B2 (en) | An antiperspirant composition | |
| US4548808A (en) | Long-acting anhydrous antiperspirant compositions containing triacetin | |
| US5135741A (en) | Antiperspirant product | |
| GB1096523A (en) | Cosmetic composition | |
| GB835385A (en) | Antiperspirant compounds | |
| US20220257480A1 (en) | An antiperspirant composition | |
| US20210299009A1 (en) | Silicone oil free antiperspirants | |
| US4490354A (en) | Antiperspirant method containing vanadium salts | |
| US6485715B1 (en) | Stable pressurized antiperspirant compositions containing dimethylether propellant and a low polarity solvent | |
| JP2018203683A (en) | Antiperspirant composition | |
| EP3941593B1 (en) | An antiperspirant composition comprising reactive salts | |
| US5888486A (en) | Antiperspirant compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8103369-8 Effective date: 19910123 Format of ref document f/p: F |